VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 492 filers reported holding VANECK VECTORS ETF TR in Q3 2019. The put-call ratio across all filers is 0.82 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $458,000 | -60.9% | 16,740 | -45.2% | 0.32% | -49.1% |
| Q1 2022 | $1,170,000 | +19.8% | 30,529 | 0.0% | 0.63% | +31.3% |
| Q4 2021 | $977,000 | +8.7% | 30,529 | 0.0% | 0.48% | +103.8% |
| Q3 2021 | $899,000 | -13.3% | 30,529 | 0.0% | 0.24% | +9.8% |
| Q2 2021 | $1,037,000 | +4.5% | 30,529 | 0.0% | 0.21% | +3.4% |
| Q1 2021 | $992,000 | -92.2% | 30,529 | -91.3% | 0.21% | -92.8% |
| Q4 2020 | $12,697,000 | -8.0% | 352,529 | 0.0% | 2.88% | -9.5% |
| Q3 2020 | $13,804,000 | +6.8% | 352,529 | 0.0% | 3.18% | -16.9% |
| Q2 2020 | $12,929,000 | -25.7% | 352,529 | -53.3% | 3.83% | -70.7% |
| Q1 2020 | $17,393,000 | +331.9% | 754,929 | +448.8% | 13.07% | +781.6% |
| Q4 2019 | $4,027,000 | +8.6% | 137,564 | -0.9% | 1.48% | -31.8% |
| Q3 2019 | $3,708,000 | +3.7% | 138,847 | -0.8% | 2.18% | +29.2% |
| Q2 2019 | $3,576,000 | -33.3% | 139,908 | -41.5% | 1.68% | -13.1% |
| Q1 2019 | $5,359,000 | +7.2% | 239,034 | +0.8% | 1.94% | +43.7% |
| Q4 2018 | $5,000,000 | -7.8% | 237,083 | -3.9% | 1.35% | -56.9% |
| Q1 2018 | $5,424,000 | +250.2% | 246,797 | +270.3% | 3.13% | +254.5% |
| Q4 2017 | $1,549,000 | – | 66,655 | – | 0.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |